Cargando…
Upregulated anti-angiogenic miR-424-5p in type 1 diabetes (model of subclinical cardiovascular disease) correlates with endothelial progenitor cells, CXCR1/2 and other parameters of vascular health
BACKGROUND: In spite of clinical progress, cardiovascular disease (CVD) remains the predominant cause of mortality worldwide. Overexpression studies in animals have proven miR-424-5p to have anti-angiogenic properties. As type 1 diabetes mellitus (T1DM) without CVD displays endothelial dysfunction a...
Autores principales: | Tamara, Alice, Coulson, David J., Latief, Jevi Septyani, Bakhashab, Sherin, Weaver, Jolanta U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120744/ https://www.ncbi.nlm.nih.gov/pubmed/33985567 http://dx.doi.org/10.1186/s13287-021-02332-7 |
Ejemplares similares
-
MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus)
por: Coulson, David J., et al.
Publicado: (2021) -
The Role of miR-342 in Vascular Health. Study in Subclinical Cardiovascular Disease in Mononuclear Cells, Plasma, Inflammatory Cytokines and PANX2
por: Ray, Sabina L., et al.
Publicado: (2020) -
Subclinical Thyrotoxicosis and Cardiovascular Risk: Assessment of Circulating Endothelial Progenitor Cells, Proangiogenic Cells, and Endothelial Function
por: Phowira, Jason, et al.
Publicado: (2022) -
Upregulated miR-18a-5p in Colony Forming Unit-Hill’s in Subclinical Cardiovascular Disease and Metformin Therapy; MERIT Study †
por: Phowira, Jason, et al.
Publicado: (2022) -
Deciphering the Role of miR-200c-3p in Type 1 Diabetes (Subclinical Cardiovascular Disease) and Its Correlation with Inflammation and Vascular Health
por: Bakhashab, Sherin, et al.
Publicado: (2022)